Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial

: Background: Most hypertensive renal transplant recipients require two or more antihypertensive medications to achieve blood pressure control. However, which medications must be combined is still a matter of debate. Methods: A prospective randomized open‐label blinded evaluation trial comparing the six‐month effects of the amlodipine–enalapril combination (n = 32) vs. enalapril alone (n = 33) and vs. amlodipine alone (n = 34) on arterial pressure, renal function, albuminuria and tolerability. Results: At six months, diastolic arterial pressure was more adequately controlled (i.e.,